This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

RNA Leaders USA
RNA breakthroughs, Case Studies and Partnerships
September 23-25, 2026Hynes Convention Center

Andrew Varley
RNA & Formulation Core Director at The University of British Columbia
Speaker

Profile

Andrew Varley is Director of UBC's RNA & Formulation Core, where he leads manufacturing, analytical, and platform development efforts supporting next-generation RNA therapeutics. He established the facility and developed capabilities spanning mRNA, saRNA, and circRNA, enabling projects from early screening through large-animal studies while supporting dozens of external partners. Andrew supports global RNA therapeutics development as an Executive Committee member and Board Director of the Society for RNA Therapeutics and directs R&D initiatives focused on RNA manufacturing innovation, analytical characterization, and IVT process standards, including methods for detecting and controlling dsRNA impurities. His work accelerates translation from discovery to preclinical development.